Cholesterol in mood and anxiety disorders: Review of the literature and new hypotheses

European Neuropsychopharmacology

Volumn 14, Issue 2, 2004, Pages 135-142

  Papakostas, George I ^a   Öngür, Dost ^a   Iosifescu, Dan V ^a   Mischoulon, David ^a   Fava, Maurizio ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anxiety; Cholesterol; Depression; Fluidity; Membrane; Suicide

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; CHOLESTEROL; FENFLURAMINE; FLUOXETINE; NORTRIPTYLINE; TRAZODONE;

ANXIETY DISORDER; CELL MEMBRANE FLUIDITY; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; DRUG EFFECT; DRUG RECEPTOR BINDING; GENERALIZED ANXIETY DISORDER; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHOLESTEROLEMIA; MAJOR DEPRESSION; MOOD DISORDER; NERVE CELL MEMBRANE; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC SYSTEM; SUICIDE;

EID: 0842307090     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(03)00099-3     Document Type: Article

References (109)

1. Agargun M.Y., Algun E., Sekeroglu R., Kara H., Tarakcioglu M. Low cholesterol level in patients with panic disorder: the association with major depression. J. Affect. Disord. 50:1998;29-32.
2. Alexopoulos G.S., Meyers B.S., Young R.C., Campbell S., Silbersweig D., Charlson M. 'Vascular depression' hypothesis. Arch. Gen. Psychiatry. 54:(10):1997;915-922.
3. Alvarez J.C., Cremniter D., Lesieur P., Gregoire A., Gilton A., Macquin-Mavier I., et al. Low blood cholesterol and low platelet serotonin levels in violent suicide attempters. Biol. Psychiatry. 45:(8):1999;1066-1069.
4. Alvarez J.C., Cremniter D., Gluck N., Quintin P., Leboyer M., Berlin I., et al. Low serum cholesterol in violent but not in non-violent suicide attempters. Psychiatry Res. 95:(2):2000;103-108.
5. Atmaca M., Kuloglu M., Tezcan E., Ustundag B., Gecici O., Firidin B. Serum leptin and cholesterol values in suicide attempters. Neuropsychobiology. 45:2002;124-127.
6. Bajwa W.K., Asnis G.M., Sanderson W.C., et al. High cholesterol levels in patients with panic disorder. Am. J. Psychiatry. 149:(3):1992;376-378.
7. Baldessarini R.J. The neuropharmacology of S-adenosyl-L-methionine. Am. J. Med. 83:1987;95-103.
8. Barenholz Y. Cholesterol and other membrane active sterols: from membrane evolution to rafts. Prog. Lipid Res. 41:2002;1-5.
9. Baumann M.H., Mash D.C., Staley J.K. The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain. Neuroreport. 6:(16):1995;2150-2152.
10. Becher A., White J., McIlhinney R., Jeffrey R.A. The [gamma] -aminobutyric acid receptor B, but not the metabotropic glutamate receptor type-1, associates with lipid rafts in the rat cerebellum. J. Neurochem. 79:(4):2001;787-795.
11. Bilici M., Efe H., Koroglu M.A., Uydu H.A., Bekaroglu M., Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatment. J. Affect. Disord. 64:(1):2001;43-51.
12. Block E.R., Edwards D. Effect of plasma membrane fluidity on serotonin transport by endothelial cells. Am. J. Physiol. 243:(5 Pt 1):1987;C672-C678.
13. Block E.R., Patel J.M., Angelides K.J., Sheridan N.P., Garg L.C. Hyperoxia reduces plasma membrane fluidity: a mechanism for endothelial cell dysfunction. J. Appl. Physiol. 60:(3):1986;826-835.
14. Bocchetta A., Chillotti C., Carboni G., Oi A., Ponti M., Del Zompo M. Association of personal and familial suicide risk with low serum cholesterol concentration in male lithium patients. Acta Psychiatr. Scand. 104:(1):2001;37-41.
15. Boston P.F., Dursun S.M., Reveley M.A. Cholesterol and mental disorder. Br. J. Psychiatry. 169:(6):1996;682-695.
16. Bruses J.L., Chauvet N., Rutishauer U. Membrane lipid rafts are necessary for the maintenance of alpha 7 nicotinic acetylcholine receptor in somatic spines of ciliary neurons. J. Neurosci. 21:2001;504-512.
17. Cadeddu G., Fioravanti P., Antonicelli R., et al. Relationship between cholesterol levels and depression in the elderly. Minerva Med. 86:(6):1995;251-256.
18. Charney D.S., Redmond E.E. Neurobiological mechanisms in human anxiety: evidence supporting central noradrenergic hyperactivity. Neuropharmacology. 22:1983;1531-1536.
19. Cleare A.J., Murray R.M., O'Keane V. Assessment of serotonergic function in major depression using D-fenfluramine: relation to clinical variables and antidepressant response. Biol. Psychiatry. 44:(7):1998;555-561.
20. Coccaro E.F., Kavoussi R.J., Oakes M., Cooper T.B., Hauger R. 5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to D-fenfluramine challenge in physically healthy human subjects. Psychopharmacology (Berlin). 126:(1):1996;24-30.
21. Coccaro E.F., Kavoussi R.J., Trestman R.L., Gabriel S.M., Cooper T.B., Siever L.J. Serotonin function in human subjects: intercorrelations among central 5-HT indices and aggressiveness. Psychiatry Res. 73:(1-2):1997;1-14.
22. Cohen R.A., Zitnay K.M., Haudenschild C.C., Cunningham L.D. Loss of selective endothelial cell vasoactive functions caused by hypercholesterolemia in pig coronary arteries. Circ. Res. 63:(5):1988;903-910.
23. Cowen P.J. Serotonin receptor subtypes in depression: evidence from studies in neuroendocrine regulation. Clin. Neuropharmacol. 16:(Suppl. 3):1993;S6-S18.
24. Ellison L.F., Morrison H.I. Low serum cholesterol concentration and risk of suicide. Epidemiology. 12:(2):2001;168-172.
25. Engelberg H. Low serum cholesterol and suicide. Lancet. 339:1992;727-729.
26. Fan Q.W., Yu W., Gong J.S., Zou K., Sawamura N., Senda T., et al. Cholesterol-dependent modulation of dendrite outgrowth and microtubule stability in cultured neurons. J. Neurochem. 80:(1):2000;178-190.
27. Fava M. Anger outbursts in unipolar depressive disorders. Encephale. 23:(Spec. No. 3):1997;39-42.
28. Fava M. Depression with anger attacks. J. Clin. Psychiatry. 59:(Suppl. 8):1998;18-22.
29. Fava M., Rosenbaum J.F. Anger attacks in depression. Depress. Anxiety. 8:(Suppl):1998;59-63.
30. Fava M., Abraham M., Pava J., Shuster J., Rosenbaum J. Cardiovascular risk factors in depression: the role of anxiety and anger. Psychosomatics. 37:1996;31-37.
31. Fava M., Vuolo R.D., Wright E.C., Nierenberg A.A., Alpert J.E., Rosenbaum J.F. Fenfluramine challenge in unipolar depression with and without anger attacks. Psychol. Res. 94:(1):2000;9-18.
32. Figueroa D.J., Morris J.A., Ma L., Kandpal G., Chen E., Li Y., Austin C. Presenilin-dependant gamma-secretase activity modulates neurite outgrowth. Neurobiol. Dis. 9:2002;49-60.
33. Freedman D.S., Byers T., Barrett D.H., et al. Plasma lipid levels and psychologic characteristics in men. Am. J. Epidemiol. 141:(6):1995;507-517.
34. Gallerani M., Manfredini R., Caracciolo S., Scapoli C., Molinari S., Fersini C. Serum cholesterol concentrations in parasuicide. Br. Med. J. 310:(6995):1995;1632-1636.
35. Garland M., Hickey D., Corvin A., Golden J., Fitzpatrick P., Cunningham S., et al. Total serum cholesterol in relation to psychological correlates in parasuicide. Br. J. Psychiatry. 177:2000;77-83.
36. Ghaemi S.M., Shields G.S., Hegarty J.D., et al. Cholesterol levels in mood disorders: high or low? Bipolar Disord. 2:2000;60-64.
37. Golier J.A., Marzuk P.M., Weiner C., Tardiff K. Low serum cholesterol level and attempted suicide. Am. J. Psychiatry. 152:(3):1995;419-423.
38. Haines T.H. Do sterols reduce proton and sodium leaks through lipid bilayers? Prog. Lipid Res. 40:2002;299-324.
39. Hawton K., Cowen P., Owens D., et al. Low serum cholesterol and suicide. Br. J. Psychiatry. 162:1993;818-825.
40. Hayward C., Taylor C.B., Roth W.T., King R., Agras W.S. Plasma lipid levels in patients with panic disorder or agoraphobia. Am. J. Psychiatry. 146:1989;917-919.
41. Horsten M., Wamala S.P., Vingerhoets A., Orth-Gomer K. Depressive symptoms, social support, and lipid profile in healthy middle-aged women. Psychosom. Med. 59:1997;521-528.
42. Kagan B.L., Leskin G., Haas B., Wilkins J., Foy D. Elevated lipid levels in Vietnam veterans with chronic posttraumatic stress disorder. Biol. Pscyhiatry. 45:1999;374-377.
43. Kahn R.S., Wetzler S. m-Chlorophenylpiperazine as a probe of serotonin function. Biol. Psychiatry. 30:(11):1991;1139-1166.
44. Kim Y.K., Lee H.J., Yoon D.K., Choi S.H., Lee M.S. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr. Scand. 105:(2):2002;141-148.
45. Krishnan K.R., Hays J.C., Blazer D.G. MRI-defined vascular depression. Am. J. Psychiatry. 154:(4):1997;497-501.
46. Kuczmierczyk A.R., Barbee J.G., Bologna N.A., Townsend M.H. Serum cholesterol levels in patients with generalized anxiety disorder (GAD) and with GAD and comorbid depression. Can. J. Psychiatry. 41:1996;465-468.
47. Kunugi H., Takei N., Aoki H., Nanko S. Low serum cholesterol in suicide attempters. Biol. Psychiatry. 41:(2):1997;196-200.
48. Lamping K.G., Nuno D.W., Chappell D.A., Faraci F.M. Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. Am. J. Physiol. 276:(4 Pt 2):1999;R1023-1029.
49. Lindberg G., Larsson G., Setterlind S., Rastam L. Serum lipids and mood in working men and women in Sweden. Epidemiol. Commun. Health. 48:1994;360-363.
50. Maes M., Delanghe J., Meltzer H.Y., et al. Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research. Acta Psychiatr. Scand. 90:1994;252-258.
51. Maes M., Smith R., Christophe A., Vandooleaghe E., Van Gastel A., Neels H., et al. Lower serum high-density lipoprotein cholesterol (HDL-C) in major depression and in depressed men with serious suicidal attempts: relationship with immune-inflammatory markers. Acta Psychiatr. Scand. 95:(3):1997;212-221.
52. Maes M., De Vos N., Pioli R., Demets P., Wauters A., Neels H., et al. Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J. Affect. Disord. 58:(3):2000;241-246.
53. Malone K.M., Thase M.E., Mieczkowski T., Myers J.E., Stull S.D., Cooper T.B., et al. Fenfluramine challenge test as a predictor of outcome in major depression. Psychopharmacol. Bull. 29:(2):1993;155-161.
54. Mauch D.H., Nagler K., Schumacher S., Goritz C., Muller E.C., Otto A., et al. CNS synaptogenesis promoted by glia-derived cholesterol. Science. 294:(5545):2001;1354-1355.
55. McBride P.A., Tierney H., DeMeo M., Chen J.S., Mann J.J. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol. Psychiatry. 27:(10):1990;1143-1155.
56. McCallum J., Simons L., Simons J., et al. Low serum cholesterol is not associated with depression in the elderly: data from an Australian community study. Aust. NZ J. Med. 24:(5):1994;561-564.
57. McDuffie J.E., Coaxum S.D., Maleque M.A. 5-Hydroxytryptamine evokes endothelial nitric oxide synthase activation in bovine aortic endothelial cell cultures. Proc. Soc. Exp. Biol. Med. 221:(4):1999;386-390.
58. Meltzer H.Y., Maes M. Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men. Psychiatry Res. 58:(2):1995;89-98.
59. Michikawa M., Yanagisawa K. Inhibition of cholesterol production but not of non-sterol isoprenoid products induces neuronal cell death. J. Neurochem. 72:(6):1999;2278-3385.
60. Modai I., Valevski A., Dror S., Weizman A. Serum cholesterol levels and suicidal tendencies in psychiatric inpatients. J. Clin. Psychiatry. 55:(6):1994;252-254.
61. Morgan R.E., Palinkas L.A., Barrett-Connor E.L., Wingard D.L. Plasma cholesterol and depressive symptoms in older men. Lancet. 341:(8837):1993;75-79.
62. Muldoon M.F., Rossouw J.E., Manuch S.B., et al. Effects of a low-fat diet on brain serotonergic responsivity in cynomolgus monkeys. Biol. Psychiatry. 31:1992;739-742.
63. Mylecharane E.J. Mechanisms involved in serotonin-induced vasodilatation. Blood Vessels. 27:(2-5):1990;116-126.
64. O'Driscoll G., Green D., Taylor R.R. Simvastatin, an HMG-coenzyme: a reductase inhibitor, improve endothelial function within 1 month. Circulation. 94:1997;258-265.
65. Ohvo-Rekika H., Ramtedt B., Leppimaki P., Slotte P. Cholesterol interactions with phospholipids in membranes. Prog. Lipid Res. 41:2002;66-97.
66. Olusi S.O., Fido A.A. Serum lipid concentrations in patients with major depressive disorder. Biol. Psychiatry. 40:(11):1996;1128-1131.
67. Papakostas G.I., Petersen T., Sonawalla S., Merens W., Alpert J.E., Iosifescu D.V., Fava M., Nierenberg A.A. Serum cholesterol in treatment-resistant depression. Neuropsychobiology. 47:(3):2003;146-151.
68. Papakostas G.I., Petersen T., Hughes M., Fava M. Serum cholesterol and serotonergic-receptor sensitivity in major depressive disorder. Psychiatry Res. 118:(2):2003;137-145.
69. Papassotiropoulos A., Hawellek B., Frahnert C., Rao G.S., Rao M.L. The risk of acute suicidality in psychiatric inpatients increases with low plasma cholesterol. Pharmacopsychiatry. 32:(1):1999;1-4.
70. Partonen T., Haukka J., Virtamo J., Taylor P.R., Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. Br. J. Psychiatry. 175:(9):1989;259-262.
71. Patel J.M., Block E.R. Nitrogen dioxide-induced changes in cell membrane fluidity and function. Am. Rev. Respir. Dis. 134:(6):1986;1196-1202.
72. Penttinen J. Hypothesis: low serum cholesterol, suicide and interleukin-2. Am. J. Epidemiol. 141:1995;716-718.
73. Perticone F., Ceravalo R., Miao R., Cloro C., Candigliota M., Scozzafava A., Mongiardo A., Masrtoroberto P., Chello M., Mattioli P.L. Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients. Atherosclerosis. 152:2000;511-518.
74. Peter H., Hand I., Hohagen F., Koenig A., Mindermann O., Oeder F., Wittich W. Serum cholesterol level comparison: control subjects, anxiety disorder patients, and obsessive-compulsive disorder patients. Can. J. Psychiatry. 47:(6):2002;557-561.
75. Rabe-Jablonska J., Poprawska I. Levels of serum total cholesterol and LDL-cholesterol in patients with major depression in acute period and remission. Med. Sci. Monit. 6:(3):2000;539-547.
76. Rafter D. Biochemical markers of anxiety and depression. Psychiatry Res. 103:(1):2001;93-96.
77. Refolo L.M., Pappolla M.A., LaFrancois J., Malester B., Schmidt S.D., Thomas-Bryandt T., et al. A cholesterol-lowering drug reduces β-amyloid pathology in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 8:(5):2001;890-899.
78. Rosenbaum J.F., Fava M., Pava J.A., McCarthy M.K., Steingard R.J., Bouffides E. Anger attacks in unipolar depression, Part 2: Neuroendocrine correlates and changes following fluoxetine treatment. Am. J. Psychiatry. 150:(8):1993;1164-1168.
79. Sarchiapone M., Camardese G., Roy A., Della Casa S., Satta M.A., Gonzalez B., et al. Cholesterol and serotonin indices in depressed and suicidal patients. J. Affect. Disord. 62:(3):2001;217-219.
80. Scanlon S.M., Williams D.C., Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry. 40:(35):2001;10507-10513.
81. Sevincok L., Buyukozturk A., Dereboy F. Serum lipid concentrations in patients with comorbid generalized anxiety disorder and major depressive disorder. Can. J. Psychiatry. 46:2001;68-71.
82. Sheridan N.P., Block E.R. Serotonin transport and fluidity in plasma membrane vesicles: effects of hyperoxia. Am. J. Physiol. 256:(6 Pt 1):1988;C781-787.
83. Shie F.S., Jin L.W., Cook D.G., Leverenz J.B., LeBoeuf R.C. Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice. Neuroreport. 13:(4):2002;455-459.
84. Shimokawa H., Vanhoutte P.M. Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis. Circ. Res. 64:(5):1989;900-914.
85. Simons K., Ikonen E.L. Functional rafts in cell membranes. Nature. 87:1997;569-572.
86. Smith C.C., Betteridge D.J. Reduced platelet serotonin content and release in familial hypercholesterolaemia. Atherosclerosis. 130:(1-2):1997;87- 92.
87. Sonawalla S., Papakostas G.I., Petersen T., Smith M., Sickinger A.H., Israel J.A., et al. Elevated cholesterol levels in major depressive disorder associated with non-response to fluoxetine treatment. Psychosomatics. 43:(4):2002;310-316.
88. Sooksawate T., Simmonds M.A. Increased membrane cholesterol reduces the potentiation of GAAB(A) currents by neurosteroids in dissociated hippocampal neurons. Neuropharmacology. 37:(9):1998;1103-1110.
89. Sooksawate T., Simmonds M.A. Effects of membrane cholesterol on the sensitivity of the GABA(A) receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology. 40:(2):2001;178-184.
90. Sooksawate T., Simmonds M.A. Influence of membrane cholesterol on modulation of the GABA(A) receptor by neuroactive steroids and other potentiators. Br. J. Pharmacol. 134:(6):2001;1303-1311.
91. Steegmans P.H.A., Fekkes D., Hoes A.W., et al. Low serum cholesterol concentration and serotonin metabolism in men. Br. Med. J. 312:1996;21.
92. Steegmans P.H., Hoes A.W., Bak A.A., Van der Does E., Grobbee D.E. Higher prevalence of depressive symptoms in middle-aged men with low serum cholesterol levels. Psychosom. Med. 62:(2):2000;205-211.
93. Stroes E.S.G., Koomans H.A., Bruin T.W.A., de Rabelink T.J. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 346:1995;467-471.
94. Stroes E., de Bruin T., de Valk H., Erkelens W., Banga J.D., van Rijn H., et al. NO activity in familial combined hyperlipidemia: potential role of cholesterol remnants. Cardiovasc. Res. 36:(3):1997;445-452.
95. Suarez E.C. Relations of trait depression and anxiety to low lipid and lipoprotein concentrations in healthy young adult women. Psychosom. Med. 61:1999;273-279.
96. Sullivan P.F., Joyce P.R., Bulik C.M., Mulder R.T., Oakley-Browne M. Total cholesterol and suicidality in depression. Biol. Psychiatry. 36:(7):1994;472-477.
97. Suzuki T., Ito J., Takagi H., Saitho F., Shimizu H. Biochemical evidence localization of AMPA-type glutamate receptor subunits in the dendritic raft. Brain Res. Mol. Brain Res. 89:(1-2):2001;20-28.
98. Terao T., Yoshimura R., Ohmori O., Takano T., Takahashi N., Iwata N., et al. Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects. Biol. Psychiatry. 41:(9):1997;974-978.
99. Terao T., Iwata N., Kanazawa K., Takano T., Takahashi N., Hayashi T., Sugawara Y. Low serum cholesterol levels and depressive state in human dock visitors. Acta Psychiatr. Scand. 101:(3):2000;231-234.
100. Terao T., Nakamura J., Yoshimura R., Ohmori O., Takahashi N., Kojima H., et al. Relationship between serum cholesterol levels and meta- chlorophenylpiperazine-induced cortisol responses in healthy men and women. Psychiatry Res. 96:2000;167-173.
101. Thiele B., Brink I., Ploch M. Modulation of cytokine expression by hypericum extract. J. Geriatr. Psychiatry Neurol. 7:(Suppl. 1):2002;S60-S62.
102. Thomas A.J., Ferrier I.N., Kalaria R.N., Perry R.H., Brown A., O'Brien J.T. A neuropathological study of vascular factors in late-life depression. J. Neurol. Neurosurg. Psychiatry. 70:2001;83-87.
103. Verbeuren T.J., Mennecier P., Laubie M. 5-Hydroxytryptamine-induced vasodilatation in the isolated perfused rat kidney: are endothelial 5-HT1A receptors involved? Eur. J. Pharmacol. 201:(1):1991;17-27.
104. Villacres E.C., Hollifield M., Katon W.J. Sympathetic nervous system activity in panic disorder. Psychiatry Res. 21:1987;213-221.
105. Wahrle S., Das P., Nyborg A.C., McLendon C., Shoji M., Kawarabayashi T., et al. Cholesterol-dependant γ-secretase activity in buoyant cholesterol-rich membrane microdomains. Neurobiol. Dis. 9:2002;11-23.
106. Weidner G., Connor S.L., Hollis J.F., Connor W.E. Improvements in hostility and depression in relation to dietary change and cholesterol lowering: The Family Heart Study. Ann. Intern. Med. 117:1992;820-823.
107. Whiting M.V., Cambridge D. Canine renovascular responses to sumatriptan and 5-carboxamidotryptamine: modulation through endothelial 5-HT1-like receptors by endogenous nitric oxide. Br. J. Pharmacol. 114:(5):1995;969-974.
108. Yamada K., Tsutsumi T., Fujii I. Serum cholesterol levels in patients with panic disorders: a comparison with major depression and schizophrenia. Psychiatry Res. 102:(2):2001;153-162.
109. Zureik M., Courbon D., Ducimetierre P. Serum cholesterol and death from suicide in men: Paris prospective study I. Br. Med. J. 313:(7058):1996;649-651.